kephalins in the postulated enkephalin system mediating pain and analgesia. The pharmacologic characterization of the opiate-like pentapeptides [Met] enkephalin and [Leu] enkephalin revealed that intracerebralventricular (1, 2) or spinal subarachnoid (3) administration can produce a behaviorally defined analgesia in response to nociceptive stimuli. The opiate actions of these peptides suggest that they may be endogenous ligands for the opiate receptor. The distribution of enkephalin-containing neurons, the transient analgesic action of [Metlenkephalin and [Leu]enkephalin in laboratory animals, and reports of enkephalin-like material in human cerebrospinal fluid during stimulation produced analgesia have led some workers to propose that the enkephalins are involved in brain systems modulating the perception of pain (4, 5) . Although the enkephalins were first isolated from mammalian brain (6) , they are now known to be present in other tissues, including intestine and adrenal medulla (7) . Recent studies of the biosynthetic pathway of the enkephalins by Stern et al. (7) led to the isolation from adrenal chromaffin granules of several novel enkephalin-containing peptides and proteins. One of these, the heptapeptide [Met]enkephalin-Arg6-Phe7, which is also present in beef striatum, human putamen, and human globus pallidus (8) Analgesic (Antinociceptive) Assay. Analgesic activity after i.c.v. administration of opioid was measured by the radiant-heat tail-flick procedure of D'Amour and Smith (11) as modified by Dewey et al. (12) . A control latency of 2-4 sec and a cutoff time of 10 sec were used. The response was calculated as the percentage of maximal response by the following formula (13) : [(test -control)/(10 -control)] X 100 = % maximal possible effect. Dose-response curves were constructed by plotting the percent maximal possible effect against the logarithm of the dose on probit paper. The median effective dose (ED5o), slope, and relative potency ratios with their 95% confidence limits were calculated by the method of Litchfield and Wilcoxon (14) .
At least eight mice were tested at each dose with three or four dose levels used to determine each ED5o.
Antidiarrheal Assay. Antidiarrheal activity after i.v. administration of opioid was assessed by the suppression of prostaglandin E2-induced diarrhea, by the method of Sanner (15) .
Antidiuretic Assay. Antidiuretic activity after i.v. administration of opioid was assessed by the prolongation of the excretion of intraperitoneally administered water, by the method of Inturrisi and Fujimoto (16) . RESULTS 
AND DISCUSSION
The analgesic dose-response curves after i.c.v. administration of the compounds of interest are given in Fig. 1 
